It was Chennai's fifth win from nine matches as they moved to third place in the points table with 10 points
cricket9 hours ago
Ten Covid-19 vaccines could be available by the middle of next year if they win regulatory approval, but their inventors need patent protection, the head of the global pharmaceutical industry group said on Friday.
Vaccines by Pfizer and BioNtech, as well as Moderna and AstraZeneca have shown promising results in large clinical trials, but there is no question of “cutting corners”, said Thomas Cueni, director-general of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA).
“So far 3 we have 3 out of 3 were hits. I would expect that we will see something similar with Johnson & Johnson, I would expect that we would see similar positive results with Novavax, and many others, Sanofi Pasteur, GSK are in there, Merck,” he said.
‘Big Pharma’ and biotech firms have invested heavily in research and development and in boosting manufacturing during the pandemic to be able to roll out vaccine doses, Cueni told a Geneva news briefing.
It would be a mistake to lift patent protection to allow compulsory licensing and try to make vaccines requiring such complex quality assurance without expert staff and quality control procedures, he said.
“We will hopefully by the next summer have probably 10 vaccines which have proven their value. But all of them really need to be submitted by rigorous scientific scrutiny by the regulators.”
At the World Trade Organization (WTO), India and South Africa have proposed allowing a temporary waiver to allow compulsory licensing for patented products during the pandemic. The United States, European Union and Switzerland and others have rejected it, trade officials say.
Cueni, asked about the proposal, said: “For me this questioning of IP is really primarily politics, but it’s politics which is not helpful because it would send very negative signals in terms of disrespect to the system which allowed the world to react so fast and so responsibly.”
Vaccine manufacturing plants often need 50 quality assurance staff making hundreds of checks during production, he said, emphasising that the companies would not exploit the pandemic.
Cueni said that IFPMA archives showed there had never been a compulsory license granted for a vaccine and pointed to the difficult technology and know-how. Nearly every member company had committed to “not-for-profit” or socially responsible pricing during the pandemic, he added.
It was Chennai's fifth win from nine matches as they moved to third place in the points table with 10 points
cricket9 hours ago
Earlier, Arsenal held on for a pulsating 3-2 win over arch rivals Tottenham
football10 hours ago
Samsung cuts through the flaff with its Galaxy Tab S6 Lite, providing all the essential features you need at an affordable price
tech reviews10 hours ago
The country has several beaches and with that comes countless options to indulge in a hearty breakfast
food10 hours ago
In a touching Instagram post, Bipasha shared adorable pictures of themselves
entertainment10 hours ago
In this opulent saga, Bhansali delves into the world of Basra pearls
entertainment10 hours ago
The news comes just two days after his rape conviction was overturned by the New York Court of Appeals
entertainment10 hours ago
The AFI Life Achievement Award is the highest accolade granted by the American Film Institute
entertainment10 hours ago